A5007407416- Liver Disease Diagnosis and Treatment
- Hepatitis C virus research
- Liver Disease and Transplantation
- Diabetes Treatment and Management
- COVID-19 Clinical Research Studies
- Hepatitis B Virus Studies
- Metabolism, Diabetes, and Cancer
- Hepatocellular Carcinoma Treatment and Prognosis
- Cardiovascular Function and Risk Factors
- Diet, Metabolism, and Disease
- Pancreatic function and diabetes
- Long-Term Effects of COVID-19
- SARS-CoV-2 and COVID-19 Research
- Cloud Computing and Resource Management
- Genetic and Kidney Cyst Diseases
- Cardiovascular Disease and Adiposity
- Respiratory Support and Mechanisms
- Software System Performance and Reliability
- Distributed and Parallel Computing Systems
- Alcohol Consumption and Health Effects
- COVID-19 diagnosis using AI
- Systemic Lupus Erythematosus Research
- Parallel Computing and Optimization Techniques
- HIV/AIDS drug development and treatment
- Diet and metabolism studies
University of Molise
2023-2025
University of Pavia
2020-2025
University of Milan
2025
University of Campania "Luigi Vanvitelli"
2015-2024
University of Salerno
2024
Fondazione Salvatore Maugeri
2023-2024
Humanitas University
2022
University of Pisa
2018-2021
Neurological Surgery
2017-2018
University of Naples Federico II
1993-2017
Multiple modifiable risk factors for late complications in patients with diabetic kidney disease (DKD), including hyperglycemia, hypertension and dyslipidemia, increase the of a poor outcome. DKD is associated very high cardiovascular risk, which requires simultaneous treatment these by implementing an intensified multifactorial approach. However, efficacy intervention on major fatal/non-fatal events (MACEs) has been poorly investigated.
In patients with Normal Glucose Tolerance (NGT) some causes of ischemic heart disease (IHD) were not completely investigated. The role both metabolic milieu and adipokines in IHD progression was fully Our aim to assess the link between plasma levels, insulin resistance (IR) NGT undergoing Percutaneous Coronary Intervention (PCI). AIRE is a single-center prospective longitudinal observational study investigating outcome subjects who underwent coronary revascularization by PCI third level...
Non-Alcoholic Fatty Liver Disease (NAFLD) is caused by the accumulation of fat in over 5% hepatocytes absence alcohol consumption. NAFLD considered hepatic manifestation metabolic syndrome (MS). Recently, an expert consensus suggested as more appropriate term MAFLD (metabolic-associated fatty liver disease). Insulin resistance (IR) plays a key role development NAFLD, it causes increase lipogenesis and inhibition adipose tissue lipolysis. Beyond imbalance adipokine levels, mass visceral also...